Showing results (221-230 of 230) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
International Journal of Molecular Sciences|July 2, 2021
Nitric Oxide Modulates Metabolic Processes in the Tumor Immune MicroenvironmentChristopher L McGinity, Erika M Palmieri, Veena Somasundaram, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2017
Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancerDebashree Basudhar, Sharon A Glynn, Madison Greer, et al.
Plos One|September 8, 2012
Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activationLisa A Ridnour, Kimberly M Barasch, Alisha N Windhausen, et al.
The Lancet. Oncology|May 29, 2021
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trialThomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2006
Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver diseaseV W S Wong, A Y Hui, S W C Tsang, et al.
Cancer Research|May 21, 2015
NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth DelayLisa A Ridnour, Robert Y S Cheng, Jonathan M Weiss, et al.
The New England Journal of Medicine|April 17, 2018
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung CancerLeena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, et al.
Cell Death & Disease|May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER<sup>-</sup> breast tumors that lead to poor outcomeRobert Y S Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patientsLisa A Ridnour, Robert Y S Cheng, William F Heinz, et al.
Cancer Research Communications|October 2, 2024
Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast CancerLisa A Ridnour, William F Heinz, Robert Y S Cheng, et al.
Pageof 23